BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 19245695)

  • 1. The HELLP syndrome: clinical issues and management. A Review.
    Haram K; Svendsen E; Abildgaard U
    BMC Pregnancy Childbirth; 2009 Feb; 9():8. PubMed ID: 19245695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HELLP syndrome.
    Kirkpatrick CA
    Acta Clin Belg; 2010; 65(2):91-7. PubMed ID: 20491358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HELLP syndrome: understanding and management of a pregnancy-specific disease.
    Aloizos S; Seretis C; Liakos N; Aravosita P; Mystakelli C; Kanna E; Gourgiotis S
    J Obstet Gynaecol; 2013 May; 33(4):331-7. PubMed ID: 23654309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aggressive versus conservative management of HELLP syndrome--a status assessment].
    Rath W
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):265-71. PubMed ID: 8766481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose dexamethasone in postpartum women with class 1 haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Takahashi A; Kita N; Tanaka Y; Tsuji S; One T; Ishiko A; Kimura F; Takahashi K; Murakami T
    J Obstet Gynaecol; 2019 Apr; 39(3):335-339. PubMed ID: 30585109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    O'Brien JM; Milligan DA; Barton JR
    Am J Obstet Gynecol; 2000 Oct; 183(4):921-4. PubMed ID: 11035338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of pregnancy-prolonging management on maternal and neonatal morbidity in HELLP syndrome].
    Hagen A; Ebert A; Lange J; Zemlin M; Hopp H
    Zentralbl Gynakol; 2001 Sep; 123(9):513-9. PubMed ID: 11709744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids.
    Tompkins MJ; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):304-9. PubMed ID: 10454673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HELLP syndrome. Review and update].
    Dreyfus M; Tissier I; Baldauf JJ; Ritter J
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):9-15. PubMed ID: 9091550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome.
    Katz L; Amorim M; Souza JP; Haddad SM; Cecatti JG;
    Reprod Health; 2013 May; 10():28. PubMed ID: 23697398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets).
    Magann EF; Roberts WE; Perry KG; Chauhan SP; Blake PG; Martin JN
    Am J Obstet Gynecol; 1994 Jun; 170(6):1828-32; discussion 1832-4. PubMed ID: 8203445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratorial profile and complications of patients with HELLP syndrome admitted in an obstetric intensive care unit].
    Katz L; Amorim MM; Miranda GV; Pinto e Silva JL
    Rev Bras Ginecol Obstet; 2008 Feb; 30(2):80-6. PubMed ID: 19142480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome.
    Magann EF; Martin RW; Isaacs JD; Blake PG; Morrison JC; Martin JN
    Aust N Z J Obstet Gynaecol; 1993 May; 33(2):127-31. PubMed ID: 8216107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of HELLP syndrome.
    Curtin WM; Weinstein L
    J Perinatol; 1999 Mar; 19(2):138-43. PubMed ID: 10642976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting maternal and perinatal outcomes in HELLP syndrome: evaluation of 126 cases.
    Erdemoğlu M; Kuyumcuoğlu U; Kale A; Akdeniz N
    Clin Exp Obstet Gynecol; 2010; 37(3):213-6. PubMed ID: 21077527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP).
    Magann EF; Bass D; Chauhan SP; Sullivan DL; Martin RW; Martin JN
    Am J Obstet Gynecol; 1994 Oct; 171(4):1148-53. PubMed ID: 7943088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of diagnosis and treatment of hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome: clinical analysis of 59 cases.
    Wang YQ; Wang J; Ye RH; Zhao YY
    Chin Med J (Engl); 2010 May; 123(10):1273-7. PubMed ID: 20529580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HELLP Syndrome at 20 Gestational Weeks Managed Using the Mississippi Protocol: A Case Report.
    Masuko N; Tanimura K; Tanaka M; Uchida A; Takahashi R; Imafuku H; Deguchi M; Terai Y
    Kobe J Med Sci; 2024 Apr; 70(1):E22-E25. PubMed ID: 38644297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing pregnancy with HIV, HELLP syndrome and low platelets.
    Onyangunga OA; Moodley J
    Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):133-47. PubMed ID: 22104081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome.
    Barton JR; Sibai BM
    Clin Perinatol; 2004 Dec; 31(4):807-33, vii. PubMed ID: 15519429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.